EFFICACY AND SAFETY OF CD-271 ALCOHOLIC GELS IN THE TOPICAL TREATMENT OF ACNE-VULGARIS

被引:48
作者
VERSCHOORE, M [1 ]
LANGNER, A [1 ]
WOLSKA, H [1 ]
JABLONSKA, S [1 ]
CZERNIELEWSKI, J [1 ]
SCHAEFER, H [1 ]
机构
[1] MED ACAD WARSAW,DEPT DERMATOL,PL-02032 WARSAW,POLAND
关键词
D O I
10.1111/j.1365-2133.1991.tb00600.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
CD 271, a naphthoic acid, is a powerful modulator of epidermal differentiation. This double-blind, randomized study compared the efficacy and safety of two concentrations (0.03% w/w and 0.1% w/w) of CD 271 alcoholic gel, with 0.025% w/w tretinoin gel in 72 male patients with acne vulgaris over a period of 12 weeks. Efficacy was measured by counting facial inflammatory and non-inflammatory lesions and by grading the severity of the acne at each visit. Skin tolerance was assessed with subjective symptoms, such as burning and pruritus, as well as clinical assessment of erythema, dryness and scaling on the treated areas. The alcoholic 0.1% CD 271 gel was as effective as 0.025% tretinoin gel in reducing total comedone counts (83% reduction for both products after 12 weeks treatment). The reduction in the number of inflammatory lesions and the total number of acne lesions were significantly greater with 0.1% CD 271 gel than with tretinoin gel (69% and 79% for 0.1% CD 271, 50% and 73% for tretinoin gel, respectively, P < 0.05). All three treatments were well tolerated and there were no changes in any major blood parameters. No CD 271 could be detected in blood plasma at the end of the study (detection limit = 1 ng/ml).
引用
收藏
页码:368 / 371
页数:4
相关论文
共 10 条
[1]   THE ASSESSMENT OF ACNE-VULGARIS - THE LEEDS TECHNIQUE [J].
BURKE, BM ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (01) :83-92
[2]   EFFICACY OF TOPICAL ISOTRETINOIN 0.05-PERCENT GEL IN ACNE-VULGARIS - RESULTS OF A MULTICENTER, DOUBLE-BLIND INVESTIGATION [J].
CHALKER, DK ;
LESHER, JL ;
SMITH, JG ;
KLAUDA, HC ;
POCHI, PE ;
JACOBY, WS ;
YONKOSKY, DM ;
VOORHEES, JJ ;
ELLIS, CN ;
MATSUDAJOHN, S ;
SHALITA, AR ;
SMITH, EB ;
RAIMER, SS ;
KNOX, JM ;
KANTOR, II .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (02) :251-254
[3]  
CHATELUS A, 1989, PHARM RETINOIDS SKIN, V3, P144
[4]   RETINOIC ACID-DERIVATIVE RO11-1430 IN ACNE-VULGARIS - CONTROLLED MULTICENTER TRIAL AGAINST RETINOIC ACID [J].
CHRISTIANSEN, J ;
HOLM, P ;
REYMANN, F .
DERMATOLOGICA, 1977, 154 (04) :219-227
[5]   COMPARATIVE EFFICACY OF ORAL ERYTHROMYCIN VERSUS ORAL TETRACYCLINE IN THE TREATMENT OF ACNE-VULGARIS - A DOUBLE-BLIND-STUDY [J].
GAMMON, WR ;
MEYER, C ;
LANTIS, S ;
SHENEFELT, P ;
REIZNER, G ;
CRIPPS, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (02) :183-186
[7]  
HENSBY CN, 1989, PHARM RETINOIDS SKIN, V3, P160
[8]   TOPICAL CLINDAMYCIN PHOSPHATE COMPARED WITH ORAL TETRACYCLINE IN THE TREATMENT OF ACNE-VULGARIS [J].
KATSAMBAS, A ;
TOWARKY, AA ;
STRATIGOS, J .
BRITISH JOURNAL OF DERMATOLOGY, 1987, 116 (03) :387-391
[9]   ERYTHROMYCIN 2-PERCENT GEL IN COMPARISON WITH CLINDAMYCIN PHOSPHATE 1-PERCENT SOLUTION IN ACNE-VULGARIS [J].
LEYDEN, JJ ;
SHALITA, AR ;
SAATJIAN, GD ;
SEFTON, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (04) :822-827
[10]  
SHROOT B, 1989, PHARM SKIN, V3, P270